NAYA Biosciences, Inc. - Common Stock NAYA 深 滬
等待開盤 07-24 09:30:00 美东时间
2.20
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 2.20
- 總市值 1032.61万
- 52周最高 51.12
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 4.14
- 委 比 0.00%
- 總股本 469.37万
- 歷史最高 8856.00
- 量 比 0
- 振 幅 0.00%
- 歷史最低 6.84
- 每 手 1
- 風險率 0.31%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多INVO Fertility Amends Securities Purchase Agreement
The latest update is out from INVO Fertility ( ($IVF) ). On June 30, 2025, NAYA...
07-01 21:09
Top 3 Health Care Stocks That May Rocket Higher This Quarter
The most oversold stocks in the health care sector presents an opportunity to b...
06-11 19:01
INVO Fertility confirms new Nasdaq trading symbol of “IVF”
INVO Fertility (NASDAQ:NAYA) confirmed it will begin trading under the new symbol “IVF” at the market open on April 28, 2025. The symbol change follows NAYA’s announcement on April 14, 2025, regarding...
04-24 21:18
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers TNF Pharmaceuticals (NASDAQ:TNFA) shares moved upwards by 19.6% to $0....
03-14 05:05
NAYA Announces 1-For-12 Reverse Stock Split Effective March 18, 2025
NAYA Biosciences, Inc. ("NAYA") (NASDAQ:NAYA), a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases, and women's health, and a leading provider
03-14 04:33
美股机会日报丨DeepSeek暴击华尔街！特朗普“发难”美联储要求降息，华尔街警告：加息信号愈发强烈
DeepSeek暴击华尔街！纳指期货盘前跌超3%，博通、英伟达跌超11%；中概股盘前走高，金山云涨超11%；特朗普“发难”美联储要求降息，华尔街却警告：加息信号愈发强烈>>
01-27 21:24
美股大行评级 | MBOT获机构看涨逾340%！大行上调NAYA评级至买入
HC Wainwright & Co.：维持Microbot Medical(MBOT)"买入"评级，目标价从7美元升至9美元
01-26 10:19
美股大行评级 | 潜在涨幅188%！Bright Minds Biosciences(DRUG)获机构首予"超配"评级，目标价93美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1089469551663222785.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Maxim Group：上调NAYA Biosciences(NAYA)评级至"买入"，目标价2美元</p> <p>• HC Wainwright & Co.：维持Nuvation Bio(NUVB)"买入"评级，
01-24 10:15
NAYA Biosciences Raises $9.5M Amid Nasdaq Compliance Issues
NAYA Biosciences ( ($NAYA) ) has provided an announcement. On January 14, 2025,...
01-17 04:27
NAYA Biosciences Announces Initiation Of Phase 1/2a Clinical Trial For Its GPC3-Targeted NK Engager Bispecific Antibody In Patients With Hepatocellular Carcinoma
NAYA Biosciences ("NAYA") (NASDAQ:NAYA), a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases, and fertility, today announced an update
2024-10-24 21:17
